Industries > Pharma > Zika Virus Testing Market Forecast 2020-2030

Zika Virus Testing Market Forecast 2020-2030

Forecasts and Analysis by Diagnostic Test Type, by End User, and Geography, with Profiles of Leading Companies

PAGES: 156
SUBMARKET: Diagnostics

WOOCS 2.2.1
SKU: PHA0712 Categories: , Tags: ,

According to the report published by Visiongain, the Zika Virus Testing market was valued at approximately USD xx million in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030. The virus Zika is a flavivirus which has Zika virus disease caused by infection. The infected Aedes species mosquitoes primarily transmit the virus. Nevertheless, Zika virus can be passed on to his or her sexual partner by an infected man. Although Zika virus infection typically is asymptomatic or induces moderate disease, a risk of Zika virus and developmental microcephaly as well as other serious brain defects occur. Molecular and serological testing are included in diagnostic tests to determine Zika virus infection. This policy outlines the requirements of the medical need for diagnostic tests.

Zika virus, more frequently spread by Ae, is mainly the bites of contaminated Aedes mosquitoes. Aegypti and perhaps Ae. Ae. Mosquitoes of albopictus. 3 Zika virus has been documented for sexually transmitted from males to their sexual partners, from 4 to females to male sexual partners. 14 The hazard assessment of Zika virus is actually of unknown interest, unless the two spouses become symptomatic and a person decides to marry, because the virus has little understanding for male genitourinary tract loss.

One of the major trends in increasing market growth is the participation of international organisations, such as UNICEF, and national governments in low-income developed countries. Moreover, a 2016 outbreak of Zika virus (ZIKV) has contributed to enormous traction of the market. In Brazil, between 2015 and 2016, there were about 1 950 cases of microcephaly in this region. A threat to public health was declared to be zika virus in October 2016, after a correlation was found between ZIKV and neurological birth defects in Brazil. This link between microcephaly in newborn babies with ZIKV has increased surveillance efforts and a demand for diagnostics since the end of the 2016 Zika epidemic. CDC reports that 5,264 individuals have been Zika infected in the U.S., where more than 1,700 pregnant women have been identified with Zika positive and 58 babies have born with birth defects.

A large part of the disease-related transmission in certain countries contributed to Zika virus in 2016. In the United States, 4,830 Zika-related cases have been reported, representing 94.0% of the overall cases for 2016. In addition to symptomatic cases testing to prevent transmission of diseases that drive the demand for ZIKV diagnostics, blood testing for Zika infection has therefore also been incorporated. In the US and Singapore, blood donations to Zika virus infections will primarily be diagnosed.

Organizations like the WHO, the PAHO and UNICEF have launched social approaches to Zika as a global impact. Such methods vary from therapeutic structures to stocks for clinical care. In addition to supporting preventive and prophylactic Zika virus studies, the organizations focus on potential emergency diagnostics, which help the market’s expansion.

Development of POC diagnostics which produce fast results can shape the market’s future. UNICEF and PAHO are proposing early buy-out agreements (APC) to facilitate fast diagnostics for the prevention of zika viruses. These APCs cover endemic areas of ZIKV that threaten potential outbreaks and require fast diagnostic testing. UNICEF has sealed contracts for the supply of their valid 2019 Zika detection tests by Chembio Diagnostics Systems, Inc. and SD Biosensors, Inc.

In 2016, NAAT and serological testing were both diagnose-test types, and held nearly equal market shares, with both tests performed on most subjects to confirm ZIKV infection during the epidemic. The NAAT segment, however, has a small margin as it is more widely available and can be used with economic efficiency for large-scale surveillance. With the conclusion of the outbreak at the start of 2017, both severe and late stage ZIKV disease began to take priority over NAAT. Furthermore, new fast serologic identification diagnostics also provide shorter turnaround times and differentiated Zika diagnosis from other flaviviruses.

Why you should buy Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis by Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing) and Geography, with Profiles of Leading Companies
What is the future of the Zika Virus Testing market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.

We guarantee in this 156 page report you will receive the following key information –
• View Zika Virus Testing market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Zika Virus Testing revenue forecast
– Zika Virus Testing connections forecast

• Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Zika Virus Testing market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Zika Virus Testing sector

• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Zika Virus Testing industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Zika Virus Testing submarkets with individual forecasts and analysis from 2020-2030.
– Diagnostic Test Type submarket forecast 2020-2030
– End User submarket forecast 2020-2030
– submarket forecast 2020-2030

• Learn about the market prospects for the leading Zika Virus Testing market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Zika Virus Testing revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.

– Diagnostic Test Type Revenue Forecast 2020-2030
– Molecular Test revenue forecast 2020-2030
– Serologic Test revenue forecast 2020-2030
– Plaque Reduction Neutralization Test revenue forecast 2020-2030
– Others revenue forecast 2020-2030

– End User Revenue Forecast 2020-2030
– Diagnostic Laboratory revenue forecast 2020-2030
– Hospital revenue forecast 2020-2030
– Clinics revenue forecast 2020-2030
– Academic Institutes revenue forecast 2020-2030
– Other revenue forecast 2020-2030

• Understand the prospects for the 4 regional and the leading 12 national Zika Virus Testing markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Zika Virus Testing companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts

• Explore the factors affecting Zika Virus Testing product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry

• Identify who the leading companies are in the Zika Virus Testing industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Zika Virus Testing companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.

Leading Companies in the Global Zika Virus Testing Market
Luminex Corporation
Primerdesign Ltd
Quest Diagnostics
ARUP Laboratories
Altona Diagnostics GmbH
Chembio Diagnostic Systems Inc.
F. Hoffmann-La Roche Ltd
Fast Track Diagnostics Ltd
Abbott Molecular

Discover Information found nowhere else in this independent assessment of the Zika Virus Testing market
The Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis By Diagnostic Test Type, By End User, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Zika Virus Testing sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.

With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.

What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030

How the Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis By Diagnostic Test Type, By End User, By and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Zika Virus Testing market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.

Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Zika Virus Testing sector and find out what its future market prospects are.

To access the data contained in this document please email

Buy our report today Zika Virus Testing Market Forecast 2020-2030: Forecasts and Analysis by Diagnostic Test Type, by End User, and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Download sample pages

Complete the form below to download your free sample pages for Zika Virus Testing Market Forecast 2020-2030

    Download sample pages

    Complete the form below to download your free sample pages for Zika Virus Testing Market Forecast 2020-2030

      Latest Pharma news

      Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

      The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.

      20 March 2023


      Visiongain Publishes eClinical Solutions Market Report 2023-2033

      The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.

      17 March 2023


      Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

      The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.

      15 March 2023


      Visiongain Publishes Regenerative Medicine Market Report 2023-2033

      The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.

      10 March 2023